MONOFERRIC (Iron Isomaltoside 1000 for Injection) 1 Indications

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

MONOFERRIC® (ferric derisomaltose for injection) is indicated for:

  • the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy.

The diagnosis must be based on laboratory tests.

1.1 Pediatrics:

Pediatrics (< 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.

1.2 Geriatrics:

A careful risk benefit assessment is required before MONOFERRIC is used in patients aged > 65 years and close monitoring for adverse events is required (see 7 WARNINGS AND PRECAUTIONS, Special Populations, Geriatrics).